Replies to post #2423 on InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[blackbandit]

yes initially it's to be safety tested on a specific size and type of spinal cord injury, which is why it is taking some time before a patient meets the criteria. After safety and some efficacy is proven, it's use could then be greatly expanded, and ultimately combined with stem cell therapy to produce a cure is the goal. NVIV has healed paralyzed monkees with this procedure, so the possiblities are very exciting. The current drag on the pps is most likely aegis selling their 1.8 mil share payment for handling the offering. But it's now been around 5 weeks or more so they should be about done. A sudden jump back over 1.20 will probably be a good sign they are done. All IMo, Do your own DD and GL